Collectively, these findings demonstrate that elevated <i>YBX1</i> expression marks proliferative and clinically aggressive tumour states within which genomic instability-related features arise in a context-dependent manner, providing a clarified pan-cancer framework for interpreting YB-1-associated tumour biology. Here, YBX1 is linked to cancer.